Does Medicare Cover Medical Marijuana?
No. Medicare does not cover medical marijuana — the cannabis plant you buy from a state-licensed dispensary — because Medicare Part D only pays for drugs the U.S. Food and Drug Administration (FDA) has approved, and the FDA has not approved the marijuana plant to treat any disease or condition. Original Medicare (Part A and Part B) does not pay for it either. However, Part D and Medicare Advantage drug plans CAN cover four FDA-approved cannabinoid prescription drugs — Epidiolex, Marinol, Syndros, and Cesamet — when they are on your plan's drug list, usually with rules like prior authorization. The federal move to reschedule certain marijuana products in April 2026 did not change this, because Medicare coverage depends on FDA approval, not on how a drug is scheduled.
Why Medicare won't pay for dispensary marijuana
Medicare's prescription drug coverage (Part D, and the drug coverage built into most Medicare Advantage plans) is limited to drugs that are approved by the FDA and that can only be dispensed by prescription. This is a requirement written into federal law that defines what counts as a 'Part D drug.' Drugs the FDA has not approved are simply excluded.
The FDA has not approved the marijuana plant — in any form — to treat any disease or condition. State medical-marijuana programs operate under state law, but a state license does not make the cannabis an FDA-approved medicine. Because dispensary marijuana is not FDA-approved, it can never meet Medicare's definition of a covered drug, no matter what your doctor recommends it for.
Original Medicare also does not help. Part A (hospital) and Part B (medical) do not pay for medical marijuana or for the cannabis plant itself — it is not a covered Part B drug or service.
The cannabis-related drugs Medicare CAN cover
There is an important difference between the marijuana plant and FDA-approved prescription drugs that are made from, or related to, cannabis. The FDA has approved exactly four such drug products. Because these are FDA-approved prescription drugs, a Part D or Medicare Advantage drug plan can cover them — but only when the specific drug is on that plan's formulary (its list of covered drugs), which varies from plan to plan.
The four FDA-approved products and their approved uses are:
- Epidiolex (cannabidiol / CBD) — a cannabis-derived liquid approved to treat seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients 1 year and older.
- Marinol (dronabinol) — a synthetic, cannabis-related drug approved for nausea from cancer chemotherapy and for anorexia (loss of appetite) with weight loss in people with AIDS.
- Syndros (dronabinol) — a liquid form of dronabinol, approved for the same uses as Marinol.
- Cesamet (nabilone) — a synthetic cannabis-related drug approved for nausea associated with cancer chemotherapy.
Coverage rules and what it can cost in 2026
Even when one of these four drugs is on your plan's formulary, coverage usually comes with restrictions. Plans commonly require prior authorization (your doctor must justify the prescription), step therapy (you may have to try other drugs first), and the approval may be time-limited. These rules differ by plan, so check your plan's drug list and your Evidence of Coverage before assuming a drug is covered.
If a doctor prescribes one of these drugs for an off-label use — a condition the FDA has not approved it for — Part D generally will not cover that use unless it is supported by one of Medicare's officially recognized drug reference guides (compendia).
When a cannabinoid drug is covered under Part D, standard Part D cost rules apply. In 2026, there is an annual out-of-pocket cap of $2,100 on covered Part D drugs, and the Part D national base beneficiary premium is $38.99 per month. Your actual premium, deductible, and copays depend on the specific plan you choose.
CBD oil and over-the-counter products are not covered
Medicare Part D does not cover nonprescription (over-the-counter) products. That means CBD oils, gummies, tinctures, and similar wellness products sold in stores or online are not covered — they are not FDA-approved prescription drugs.
The one prescription CBD product Medicare can cover is Epidiolex, and only when it is on your plan's formulary and prescribed for a covered use. A retail CBD product is not the same thing as Epidiolex, even though both contain CBD.
Medicare also will not pay for the cost of getting a medical-marijuana card or a doctor's recommendation to use medical marijuana, because the underlying product is not a covered benefit.
Did the 2026 marijuana rescheduling change anything?
You may have heard that marijuana was 'rescheduled' in 2026. Here is what actually happened — and why it does not change your Medicare coverage.
Effective April 28, 2026, a DEA final order moved a narrow category of products — FDA-approved drug products that contain marijuana, and marijuana covered by a qualifying state medical-marijuana license — from Schedule I to Schedule III of the Controlled Substances Act. The rest of the marijuana world stayed in Schedule I: recreational marijuana, bulk marijuana, marijuana extracts that are not in FDA-approved products, and synthetically derived THC all remain Schedule I controlled substances.
A separate, broader DEA administrative hearing on rescheduling marijuana more generally (also Schedule I to Schedule III) was set to begin June 29, 2026. It is still a pending process and does not, by itself, create any Medicare coverage.
Most importantly: Medicare drug coverage depends on FDA approval, not on how the DEA schedules a substance. State-licensed dispensary marijuana is still not an FDA-approved drug, so rescheduling does not make it eligible for Medicare. Medical marijuana from a dispensary remains not covered.
Could Medicare cover medical marijuana in the future?
For Medicare to pay for the cannabis plant as medicine, the FDA would generally need to approve a marijuana drug product through its normal review process, and the drug would need to be prescription-only. Until that happens, dispensary marijuana cannot meet Medicare's legal definition of a covered drug.
It is reasonable to expect more FDA-approved cannabinoid drugs over time, and any that are approved and added to a plan's formulary could be covered like other prescription drugs. But coverage of the plant itself bought from a dispensary is not on the near-term horizon. If covering an FDA-approved cannabinoid drug matters to you, compare plan formularies during enrollment, and confirm the drug, its tier, and any prior-authorization rules in writing before you enroll.
Frequently asked questions
Is Epidiolex (prescription CBD) covered by Medicare?
It can be. Epidiolex is an FDA-approved prescription CBD drug, so a Part D or Medicare Advantage drug plan can cover it when it is on the plan's formulary and prescribed for a covered seizure condition. Coverage often requires prior authorization, and it varies by plan, so check your plan's drug list. Over-the-counter CBD oil is not covered.
Are Marinol, Syndros, or Cesamet covered by Part D?
They can be. All three are FDA-approved cannabinoid prescription drugs (Marinol and Syndros are dronabinol; Cesamet is nabilone), used mainly for chemotherapy-related nausea. A Part D plan can cover them when they are on its formulary, typically with rules like prior authorization or step therapy. Whether your specific plan covers them varies — confirm in your plan documents.
Now that some marijuana is Schedule III, will Medicare start paying for it?
No. The April 2026 rescheduling moved only FDA-approved marijuana drug products and state-licensed medical marijuana to Schedule III, while recreational and most dispensary marijuana stayed in Schedule I. More importantly, Medicare coverage depends on FDA approval, not DEA scheduling. Dispensary marijuana is still not FDA-approved, so it remains not covered.
Will I owe extra costs or need prior authorization for a covered cannabinoid drug?
Often yes. Plans frequently require prior authorization, step therapy, or trying other drugs first, and approval can be time-limited. If covered, standard 2026 Part D rules apply, including a $2,100 annual out-of-pocket cap. Your specific premium and copays depend on your plan.
Does Medicare pay for my medical marijuana card or doctor's recommendation?
No. Because the marijuana itself is not a covered Medicare benefit, Medicare also does not pay for the cost of obtaining a medical-marijuana card or a physician's recommendation to use it.
Sources
Related guides
Medicare Login Guide is an independent resource and is not affiliated with or endorsed by Medicare, the Centers for Medicare & Medicaid Services, or any government agency. This article is for general information only — confirm current figures and your specific options at medicare.gov or by calling 1-800-MEDICARE.